Association of adiponectin and leptin with serum lipids and erythrocyte omega-3 and omega-6 fatty acids in dialysis patients

Clinical Nephrology

Volumn 75, Issue 3, 2011, Pages 195-203

  An, W S ^a   Son, Y K ^a   Kim, S E ^a   Kim, K H ^a   Bae, H R ^a   Lee, S ^b   Park, Y ^c   Kim, H J ^d   Vaziri, N D ^d  

^a Dong A University   (South Korea)

^b Pusan National University   (South Korea)

^c Hanyang University   (South Korea)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adiponectin; Dialysis; ESRD; Leptin; Omega 3 fatty acids

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ARACHIDONIC ACID; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSANOID; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TRIACYLGLYCEROL;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY MASS; DIALYSIS; ENERGY METABOLISM; ERYTHROCYTE; INFLAMMATION; KIDNEY FAILURE; LIPID BLOOD LEVEL; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

ADIPONECTIN; ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LEPTIN; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RENAL DIALYSIS; REPUBLIC OF KOREA; TRIGLYCERIDES;

EID: 79951861902     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP75195     Document Type: Article

References (42)

1. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, UKPDS GROUP. Development and progression of nephropathy in type 2 diabetes: The United Kingdom prospective diabetes study (UKPDS 64). Kidney Int. 2003; 63: 225-232. (Pubitemid 35463925)
2. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32: 112-119.
3. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004; 164: 659-663. (Pubitemid 38392981)
4. Vaziri ND. Dyslipidemia of chronic renal failure:The nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol. 2006; 290: 262-272.
5. Taskapan MC, Taskapan H, Sahin I, Keskin L, Atmaca H, Ozyalin F. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality. Ren Fail. 2007; 29: 147-154.
6. Cheung W, Yu PX, Little BM, Cone RD, Marks DL, Mak RH. Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest. 2005; 115: 1659-1665. (Pubitemid 40814675)
7. Stenvinkel P, Lindholm B, Lonnqvist F, Katzarski K, Heimburger O. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. JAm Soc Nephrol. 2000; 11: 1303-1309. (Pubitemid 30416227)
8. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005; 26: 439-451. (Pubitemid 40686653)
9. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002; 13: 134-141. (Pubitemid 34042020)
10. Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD. Adiponectin in peritoneal dialysis patients: A comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis. 2004; 43: 1047-1055.
11. Diez JJ, Estrada P, Bajo MA, Fernandez-Reyes MJ, Grande C, Del Peso G, Heras M, Molina A, Iglesias P, Sanchez-Villanueva R, Selgas R. High stable serum adiponectin levels are associated with a better outcome in prevalent dialysis patients. Am J Nephrol. 2009; 30: 244-252.
12. Friedman A, Moe S. Review of the effects of omega-3 supplementation in dialysis patients. Clin J Am Soc Nephrol. 2006; 1: 182-192.
13. Harris WS. N-3 fatty acids and serum lipoproteins: Human studies. Am J Clin Nutr. 1997; 65: 1645-1654.
14. Schmidt EB. N-3 fatty acids and the risk of coronary heart disease. DanMedBull. 1997; 44: 1-22. (Pubitemid 27110209)
15. Lapillonne A, Clarke SD, Heird WC. Polyunsaturated fatty acids and gene expression. Curr Opin Clin Nutr Metab Care. 2004; 7: 151-156. (Pubitemid 40340677)
16. De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA, Jr, Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb. 1994; 14: 1829-1836.
17. Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R, Lusis AJ, Mehrabian M. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med. 2004; 350: 29-37. (Pubitemid 38032181)
18. Raclot T, Groscolas R, Langin D, Ferre P. Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues. J Lipid Res. 1997; 38: 1963-1972. (Pubitemid 27468005)
19. Reseland JE, Haugen F, Hollung K, Solvoll K, Halvorsen B, Brude IR, Nenseter MS, Christiansen EN, Drevon CA. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res. 2001; 42: 743-750. (Pubitemid 32509598)
20. Itoh M, Suganami T, Satoh N, Tanimoto-Koyama K, Yuan X, Tanaka M, Kawano H, Yano T, Aoe S, Takeya M, Shimatsu A, Kuzuya H, Kamei Y, Ogawa Y. Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol. 2007; 27: 1918-1925. (Pubitemid 47315642)
21. Koerner A, Kratzsch J, Kiess W. Adipocytokines: Leptin - the classical, resistin - the controversical, adiponectin - the promising, and more to come. Best Pract Res Clin Endocrinol Metab. 2005; 19: 525-546. (Pubitemid 41819217)
22. Iwashima Y, Horio T, Kumada M, Suzuki Y, Kihara S, Rakugi H, Kawano Y, Funahashi T, Ogihara T. Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol. 2006; 98: 1603-1608. (Pubitemid 44827969)
23. Marchlewska A, Stenvinkel P, Lindholm B, Danielsson A, Pecoits-Filho R, Lonnqvist F, Schalling M, Heimburger O, Nordfors L. Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease. Kidney Int. 2004; 66: 46-50. (Pubitemid 38870080)
24. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, Kumada M, Hotta K, Nishida M, Takahashi M, Nakamura T, Shimomura I, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation. 2002; 105: 2893-2898. (Pubitemid 34666104)
25. Chen MP, Tsai JC, Chung FM, Yang SS, Hsing LL, Shin SJ, Lee YJ. Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol. 2005; 25: 821-826. (Pubitemid 40463876)
26. Steffes MW, Gross MD, Lee DH, Schreiner PJ, Jacobs DR Jr. Adiponectin, visceral fat, oxidative stress, and early macrovascular disease: The coronary artery risk development in young adults study. Obesity (Silver Spring). 2006; 14: 319-326. (Pubitemid 46214764)
27. Rao M, Li L, Tighiouart H, Jaber BL, Pereira BJ, Balakrishnan VS, HEMO Study Group. Plasma adiponectin levels and clinical outcomes among haemodialysis patients. Nephrol Dial Transplant. 2008; 23: 2619-2628.
28. Duda MK, O'Shea KM, Lei B, Barrows BR, Azimzadeh AM, McElfresh TE, Hoit BD, Kop WJ, Stanley WC. Dietary supplementation with omega-3 PUFAincreases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc Res. 2007; 76: 303-310. (Pubitemid 350198598)
29. Fernandez-Real JM, Vendrell J, Ricart W. Circulating adiponectin and plasma fatty acid profile. Clin Chem. 2005; 51: 603-609. (Pubitemid 40300237)
30. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, Guidollet J, Touboul P, Delaye J. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994; 343: 1454-1459. (Pubitemid 24176333)
31. Burns T, Maciejewski SR, Hamilton WR, Zheng M, Mooss AN, Hilleman DE. Effect of omega-3 fatty acid supplementation on the arachidonic acid: Eicosapentaenoic acid ratio. Pharmacotherapy. 2007; 27: 633-638. (Pubitemid 46700954)
32. DeFilippis AP, Sperling LS. Understanding omega-3′s. Am Heart J. 2006; 151: 564-570.
33. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372: 425-432. (Pubitemid 24365442)
34. Lee CT, Lee CH, Su Y, Chuang YC, Tsai TL, Cheni JB. The relationship between inflammatory markers, leptin and adiponectin in chronic hemodialysis patients. Int J Artif Organs. 2004; 27: 835-841. (Pubitemid 40484595)
35. Nishizawa Y, Shoji T, Tanaka S, Yamashita M, Morita A, Emoto M, Tabata T, Inoue T, Morii H. Plasma leptin level and its relationship with body composition in hemodialysis patients. Am J Kidney Dis. 1998; 31: 655-661. (Pubitemid 28158006)
36. Johansen KL, Mulligan K, Tai V, Schambelan M. Leptin, body composition, and indices of malnutrition in patients on dialysis. J Am Soc Nephrol. 1998; 9: 1080-1084. (Pubitemid 28264736)
37. Diez JJ, Iglesias P, Fernandez-Reyes MJ, Aguilera A, Bajo MA, Alvarez-Fidalgo P, Codoceo R, Selgas R. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease. Clin Endocrinol (Oxf). 2005; 62: 242-249. (Pubitemid 40203922)
38. Nordfors L, Lonnqvist F, Heimburger O, Danielsson A, Schalling M, Stenvinkel P. Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int. 1998; 54: 1267-1275.
39. Furuya R, Odamaki M, Kumagai H, Hishida A. Beneficial effects of icodextrin on plasma level of adipocytokines in peritoneal dialysis patients. Nephrol Dial Transplant. 2006; 21: 494-498. (Pubitemid 43160008)
40. Blum WF, Englaro P, Hanitsch S, Juul A, Hertel NT, Muller J, Skakkebaek NE, Heiman ML, Birkett M, Attanasio AM, Kiess W, Rascher W. Plasma leptin levels in healthy children and adolescents: Dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab. 1997; 82: 2904-2910. (Pubitemid 27385646)
41. Peyron-Caso E, Taverna M, Guerre-Millo M, Veronese A, Pacher N, Slama G, Rizkalla SW. Dietary (n-3) polyunsaturated fatty acids up-regulate plasma leptin in insulin-resistant rats. J Nutr. 2002; 132: 2235-2240. (Pubitemid 34851656)
42. Perez-Matute P, Marti A, Martinez JA, Fernandez-Otero MP, Stanhope KL, Havel PJ, Moreno-Aliaga MJ. Eicosapentaenoic fatty acid increases leptin secretion from primary cultured rat adipocytes: Role of glucose metabolism. Am J Physiol Regul Integr Comp Physiol. 2005; 288: 1682-1688.